Uday Mondal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Uday Mondal has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Devi Das
Department of Epidemiology, National Institute for Research in Bacterial Infections, Indian Council of Medical Research, Kolkata 700010, West Bengal, India
2 shared publications - Indranil Saha
Department of Epidemiology, ICMR-National Institute for Research in Bacterial Infections, Indian Council of Medical Research, Kolkata, West Bengal, India
2 shared publications - Saibal Das
Academy of Scientific and Innovative Research (An Institution of National Importance Established by an Act of Parliament) Ghaziabad India
2 shared publications - Amit Chakrabarti
ICMR-Centre for Ageing & Mental Health, Kolkata 700 091, West Bengal, India
1 shared publication - Anoop Velayudhan
Affiliation Indian Council of Medical Research, New Delhi, India
1 shared publication - Asim Saha
ICMR Centre for Ageing and Mental Health, DP-1, Sector-V, ICMR, Kolkata 700091, West Bengal, India
1 shared publication
Latest Publications
- Open Access
- 10 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 2962
Prevalence and Determinants of Never Treatment During Mass Drug Administration for Lymphatic Filariasis: A Systematic Review and Meta-Analysis
Objectives: The term “never treated” refers to individuals who self-report having never ingested tablets during any round of Mass Drug Administration (MDA) against Lymphatic Filariasis (LF). This study estimated the pooled prevalence of never-treated individuals with MDA for LF and identified factors associated with persistent non-treatment. Methods: This systematic review and meta-analysis was registered in PROSPERO [CRD420251270067] and conducted in accordance with the PRISMA 2020 guidelines. Relevant literature was identified by searching databases, i.e., PubMed, Scopus, Cochrane Central, Embase, Web of Science, and Epistemonikos from January 2000 to December 2025, and only studies published in English were included. The AXIS tool was used to assess the study quality. A random-effects model with 95% CI was applied to estimate the pooled prevalence. Subgroup, leave-one-out sensitivity, and meta-regression analyses were conducted to explore the heterogeneity. Results: Eighteen studies including 24,940 individuals showed the pooled prevalence of never treatment during all MDA rounds at 26% (95% CI: 16% to 37%, I2 = 99.7%, 95% prediction interval: 0% to 75%). Exploratory subgroup analysis indicated wide regional and MDA round-specific variations. Meta-regression indicated that publication year did not explain the variability. Common reasons for persistent non-treatment included fear of side effects, limited knowledge, difficulty swallowing the pills, and absence during drug distribution. Conclusions: Persistently never-treated populations may represent an important programmatic barrier to LF elimination. Given the very low certainty of evidence, extreme heterogeneity, and potential publication bias, these estimates should be interpreted cautiously. Future research should ensure broader geographical representation, including both urban and rural areas, and explore structural, behavioural, and socio-cultural determinants to better target high-risk groups.
- 10 September 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (18) , 2962
Open AccessPrevalence and Determinants of Never Treatment During Mass Drug Administration for Lymphatic Filariasis: A Systematic Review and Meta-Analysis
Objectives: The term “never treated” refers to individuals who self-report having never ingested tablets during any round of Mass Drug Administration (MDA) against Lymphatic Filariasis (LF). This study estimated the pooled prevalence of never-treated individuals with MDA for LF and identified factors associated with persistent non-treatment. Methods: This systematic review and meta-analysis was registered in PROSPERO [CRD420251270067] and conducted in accordance with the PRISMA 2020 guidelines. Relevant literature was identified by searching databases, i.e., PubMed, Scopus, Cochrane Central, Embase, Web of Science, and Epistemonikos from January 2000 to December 2025, and only studies published in English were included. The AXIS tool was used to assess the study quality. A random-effects model with 95% CI was applied to estimate the pooled prevalence. Subgroup, leave-one-out sensitivity, and meta-regression analyses were conducted to explore the heterogeneity. Results: Eighteen studies including 24,940 individuals showed the pooled prevalence of never treatment during all MDA rounds at 26% (95% CI: 16% to 37%, I2 = 99.7%, 95% prediction interval: 0% to 75%). Exploratory subgroup analysis indicated wide regional and MDA round-specific variations. Meta-regression indicated that publication year did not explain the variability. Common reasons for persistent non-treatment included fear of side effects, limited knowledge, difficulty swallowing the pills, and absence during drug distribution. Conclusions: Persistently never-treated populations may represent an important programmatic barrier to LF elimination. Given the very low certainty of evidence, extreme heterogeneity, and potential publication bias, these estimates should be interpreted cautiously. Future research should ensure broader geographical representation, including both urban and rural areas, and explore structural, behavioural, and socio-cultural determinants to better target high-risk groups.
- Open Access
- 12 May 2026
- Published by MDPI AG in Psychiatry International
- Vol. 7 (3) , 111
Burden of Mental Health Outcomes and Job Burnout Among Coal Mine Workers and Synthesis of Intervention Measures: A Systematic Review & Meta-Analysis
Coal mining is a hazardous occupation that can adversely affect both the physical and mental health of workers. This study aimed to estimate the pooled prevalence of various mental health outcomes and job burnout among coal miners and to summarize available intervention strategies addressing these conditions. A systematic search of scientific databases, including Scopus, Embase, PubMed and Cochrane Central, was conducted for studies published from 2000 onwards. The study protocol was registered in PROSPERO [CRD42024536144]. Methodological quality of the studies was evaluated using AXIS, ROBINS-I and RoB 2 tools. A random-effects model was applied to estimate pooled prevalences. Of the 14,048 studies identified, 34 studies were included, comprising a total of 38,996 coal miners. The pooled prevalence of job burnout was 53.75% (95% CI: 50.64–56.86%), while depressive symptoms were observed in 35.35% of coal miners (95% CI: 16.43–54.28%; I2 = 97.41%). The pooled prevalence estimates were calculated with substantial heterogeneity (I2 > 90%) and wide prediction intervals indicate considerable variability across studies. These findings should be interpreted with caution due to substantial heterogeneity across studies, which may limit the reliability of pooled estimates. A limited number of studies reported interventions, including an Integrated Approach of Yoga Therapy (IAYT) and peer-based mental health and suicide prevention programs with supervisor training, which demonstrated potential benefits; however, these findings are based on limited and methodologically heterogeneous evidence, and the overall certainty remains low. The findings highlight a substantial burden of mental health problems among coal miners and suggest important policy implications, particularly for integrating mental health screening into periodic occupational health assessments. Addressing personal, social, and work-related determinants through comprehensive workplace strategies may help improve mental well-being and support workforce sustainability in the mining sector.
- 12 May 2026
- Published by MDPI AG in Psychiatry International
- Vol. 7 (3) , 111
Open AccessBurden of Mental Health Outcomes and Job Burnout Among Coal Mine Workers and Synthesis of Intervention Measures: A Systematic Review & Meta-Analysis
Coal mining is a hazardous occupation that can adversely affect both the physical and mental health of workers. This study aimed to estimate the pooled prevalence of various mental health outcomes and job burnout among coal miners and to summarize available intervention strategies addressing these conditions. A systematic search of scientific databases, including Scopus, Embase, PubMed and Cochrane Central, was conducted for studies published from 2000 onwards. The study protocol was registered in PROSPERO [CRD42024536144]. Methodological quality of the studies was evaluated using AXIS, ROBINS-I and RoB 2 tools. A random-effects model was applied to estimate pooled prevalences. Of the 14,048 studies identified, 34 studies were included, comprising a total of 38,996 coal miners. The pooled prevalence of job burnout was 53.75% (95% CI: 50.64–56.86%), while depressive symptoms were observed in 35.35% of coal miners (95% CI: 16.43–54.28%; I2 = 97.41%). The pooled prevalence estimates were calculated with substantial heterogeneity (I2 > 90%) and wide prediction intervals indicate considerable variability across studies. These findings should be interpreted with caution due to substantial heterogeneity across studies, which may limit the reliability of pooled estimates. A limited number of studies reported interventions, including an Integrated Approach of Yoga Therapy (IAYT) and peer-based mental health and suicide prevention programs with supervisor training, which demonstrated potential benefits; however, these findings are based on limited and methodologically heterogeneous evidence, and the overall certainty remains low. The findings highlight a substantial burden of mental health problems among coal miners and suggest important policy implications, particularly for integrating mental health screening into periodic occupational health assessments. Addressing personal, social, and work-related determinants through comprehensive workplace strategies may help improve mental well-being and support workforce sustainability in the mining sector.